Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis.
Jankowski C, Guiu S, Cortet M, Charon-Barra C, Desmoulins I, Lorgis V, Arnould L, Fumoleau P, Coudert B, Rouzier R, Coutant C, Reyal F. Jankowski C, et al. Breast Cancer Res Treat. 2017 Jan;161(1):73-81. doi: 10.1007/s10549-016-4040-4. Epub 2016 Nov 2. Breast Cancer Res Treat. 2017. PMID: 27807808
[Strategies in case of metastatic sentinel lymph node in breast cancer].
Costaz H, Rouffiac M, Boulle D, Arnould L, Beltjens F, Desmoulins I, Peignaux K, Ladoire S, Vincent L, Jankowski C, Coutant C. Costaz H, et al. Among authors: jankowski c. Bull Cancer. 2020 Jun;107(6):672-685. doi: 10.1016/j.bulcan.2019.09.005. Epub 2019 Nov 4. Bull Cancer. 2020. PMID: 31699399 Review. French.
[Comparing prediction performances of 18F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after neoadjuvant chemotherapy for HER2-positive breast cancers].
Vincent L, Jankowski C, Arnould L, Coudert B, Rouzier R, Reyal F, Humbert O, Coutant C. Vincent L, et al. Among authors: jankowski c. Gynecol Obstet Fertil Senol. 2020 Sep;48(9):679-686. doi: 10.1016/j.gofs.2020.03.015. Epub 2020 Mar 20. Gynecol Obstet Fertil Senol. 2020. PMID: 32205278 French.
Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study group.
Vincent L, Jankowski C, Ouldamer L, Ballester M, Bendifallah S, Bolze PA, Akladios C, Costaz H, Lavoué V, Canlorbe G, Collinet P, Touboul C, Huchon C, Bricou A, Dridi S, Padéano MM, Bengrine L, Arnould L, Coutant C; Groupe de Recherche FRANCOGYN. Vincent L, et al. Among authors: jankowski c. Eur J Surg Oncol. 2020 Sep;46(9):1689-1696. doi: 10.1016/j.ejso.2020.04.029. Epub 2020 Apr 24. Eur J Surg Oncol. 2020. PMID: 32417154
Monitoring HSP70 exosomes in cancer patients' follow up: a clinical prospective pilot study.
Chanteloup G, Cordonnier M, Isambert N, Bertaut A, Hervieu A, Hennequin A, Luu M, Zanetta S, Coudert B, Bengrine L, Desmoulins I, Favier L, Lagrange A, Pages PB, Gutierrez I, Lherminier J, Avoscan L, Jankowski C, Rébé C, Chevriaux A, Padeano MM, Coutant C, Ladoire S, Causeret S, Arnould L, Charon-Barra C, Cottet V, Blanc J, Binquet C, Bardou M, Garrido C, Gobbo J. Chanteloup G, et al. Among authors: jankowski c. J Extracell Vesicles. 2020 May 20;9(1):1766192. doi: 10.1080/20013078.2020.1766192. eCollection 2020. J Extracell Vesicles. 2020. PMID: 32595915 Free PMC article.
Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.
Costaz H, Boulle D, Bertaut A, Rouffiac M, Beltjens F, Desmoulins I, Peignaux K, Ladoire S, Causeret S, Loustalot C, Padeano MM, Vincent L, Jankowski C, Arnould L, Coutant C. Costaz H, et al. Among authors: jankowski c. Bull Cancer. 2022 Mar;109(3):268-279. doi: 10.1016/j.bulcan.2021.09.018. Epub 2021 Nov 24. Bull Cancer. 2022. PMID: 34838310
Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry.
Kada Mohammed S, Dabakuyo Yonli TS, Desmoulins I, Manguem Kamga A, Jankowski C, Padeano MM, Loustalot C, Costaz H, Causeret S, Peignaux K, Rouffiac M, Coutant C, Arnould L, Ladoire S. Kada Mohammed S, et al. Among authors: jankowski c. Breast Cancer Res Treat. 2023 Jan;197(2):377-385. doi: 10.1007/s10549-022-06807-w. Epub 2022 Nov 23. Breast Cancer Res Treat. 2023. PMID: 36417042 Free PMC article.
249 results